Literature DB >> 25558065

Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families.

Anas M Alazami1, Nisha Patel1, Hanan E Shamseldin1, Shamsa Anazi1, Mohammed S Al-Dosari2, Fatema Alzahrani1, Hadia Hijazi1, Muneera Alshammari3, Mohammed A Aldahmesh1, Mustafa A Salih3, Eissa Faqeih4, Amal Alhashem5, Fahad A Bashiri3, Mohammed Al-Owain6, Amal Y Kentab3, Sameera Sogaty7, Saeed Al Tala8, Mohamad-Hani Temsah3, Maha Tulbah9, Rasha F Aljelaify10, Saad A Alshahwan11, Mohammed Zain Seidahmed12, Adnan A Alhadid3, Hesham Aldhalaan13, Fatema AlQallaf13, Wesam Kurdi9, Majid Alfadhel14, Zainab Babay15, Mohammad Alsogheer16, Namik Kaya1, Zuhair N Al-Hassnan6, Ghada M H Abdel-Salam17, Nouriya Al-Sannaa18, Fuad Al Mutairi14, Heba Y El Khashab19, Saeed Bohlega13, Xiaofei Jia20, Henry C Nguyen20, Rakad Hammami1, Nouran Adly1, Jawahir Y Mohamed1, Firdous Abdulwahab1, Niema Ibrahim1, Ewa A Naim21, Banan Al-Younes21, Brian F Meyer21, Mais Hashem1, Ranad Shaheen1, Yong Xiong20, Mohamed Abouelhoda21, Abdulrahman A Aldeeri22, Dorota M Monies21, Fowzan S Alkuraya23.   

Abstract

Our knowledge of disease genes in neurological disorders is incomplete. With the aim of closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous families in whom known disease genes had been excluded by autozygosity mapping and candidate gene analysis. This prescreening step led to the identification of 69 recessive genes not previously associated with disease, of which 33 are here described (SPDL1, TUBA3E, INO80, NID1, TSEN15, DMBX1, CLHC1, C12orf4, WDR93, ST7, MATN4, SEC24D, PCDHB4, PTPN23, TAF6, TBCK, FAM177A1, KIAA1109, MTSS1L, XIRP1, KCTD3, CHAF1B, ARV1, ISCA2, PTRH2, GEMIN4, MYOCD, PDPR, DPH1, NUP107, TMEM92, EPB41L4A, and FAM120AOS). We also encountered instances in which the phenotype departed significantly from the established clinical presentation of a known disease gene. Overall, a likely causal mutation was identified in >73% of our cases. This study contributes to the global effort toward a full compendium of disease genes affecting brain function.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25558065     DOI: 10.1016/j.celrep.2014.12.015

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  153 in total

1.  Diagnostic exome sequencing for patients with a family history of consanguinity: over 38% of positive results are not autosomal recessive pattern.

Authors:  Zöe Powis; Kelly D Farwell; Christina L Alamillo; Sha Tang
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

2.  Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.

Authors:  S Anazi; S Maddirevula; E Faqeih; H Alsedairy; F Alzahrani; H E Shamseldin; N Patel; M Hashem; N Ibrahim; F Abdulwahab; N Ewida; H S Alsaif; H Al Sharif; W Alamoudi; A Kentab; F A Bashiri; M Alnaser; A H AlWadei; M Alfadhel; W Eyaid; A Hashem; A Al Asmari; M M Saleh; A AlSaman; K A Alhasan; M Alsughayir; M Al Shammari; A Mahmoud; Z N Al-Hassnan; M Al-Husain; R Osama Khalil; N Abd El Meguid; A Masri; R Ali; T Ben-Omran; P El Fishway; A Hashish; A Ercan Sencicek; M State; A M Alazami; M A Salih; N Altassan; S T Arold; M Abouelhoda; S M Wakil; D Monies; R Shaheen; F S Alkuraya
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

3.  MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.

Authors:  Alexander S Brown; Pratap Meera; Banu Altindag; Ravi Chopra; Emma M Perkins; Sharan Paul; Daniel R Scoles; Eric Tarapore; Jessica Magri; Haoran Huang; Mandy Jackson; Vikram G Shakkottai; Thomas S Otis; Stefan M Pulst; Scott X Atwood; Anthony E Oro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

4.  Exome Sequencing and the Management of Neurometabolic Disorders.

Authors:  Maja Tarailo-Graovac; Casper Shyr; Colin J Ross; Gabriella A Horvath; Ramona Salvarinova; Xin C Ye; Lin-Hua Zhang; Amit P Bhavsar; Jessica J Y Lee; Britt I Drögemöller; Mena Abdelsayed; Majid Alfadhel; Linlea Armstrong; Matthias R Baumgartner; Patricie Burda; Mary B Connolly; Jessie Cameron; Michelle Demos; Tammie Dewan; Janis Dionne; A Mark Evans; Jan M Friedman; Ian Garber; Suzanne Lewis; Jiqiang Ling; Rupasri Mandal; Andre Mattman; Margaret McKinnon; Aspasia Michoulas; Daniel Metzger; Oluseye A Ogunbayo; Bojana Rakic; Jacob Rozmus; Peter Ruben; Bryan Sayson; Saikat Santra; Kirk R Schultz; Kathryn Selby; Paul Shekel; Sandra Sirrs; Cristina Skrypnyk; Andrea Superti-Furga; Stuart E Turvey; Margot I Van Allen; David Wishart; Jiang Wu; John Wu; Dimitrios Zafeiriou; Leo Kluijtmans; Ron A Wevers; Patrice Eydoux; Anna M Lehman; Hilary Vallance; Sylvia Stockler-Ipsiroglu; Graham Sinclair; Wyeth W Wasserman; Clara D van Karnebeek
Journal:  N Engl J Med       Date:  2016-05-25       Impact factor: 91.245

5.  A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition.

Authors:  Ranad Shaheen; Lu Han; Eissa Faqeih; Nour Ewida; Eman Alobeid; Eric M Phizicky; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-04-07       Impact factor: 4.132

6.  Neuronal deficiency of ARV1 causes an autosomal recessive epileptic encephalopathy.

Authors:  Elizabeth E Palmer; Kelsey E Jarrett; Rani K Sachdev; Fatema Al Zahrani; Mais Omar Hashem; Niema Ibrahim; Hugo Sampaio; Tejaswi Kandula; Rebecca Macintosh; Rajat Gupta; Donna M Conlon; Jeffrey T Billheimer; Daniel J Rader; Kouichi Funato; Christopher J Walkey; Chang Seok Lee; Christine Loo; Susan Brammah; George Elakis; Ying Zhu; Michael Buckley; Edwin P Kirk; Ann Bye; Fowzan S Alkuraya; Tony Roscioli; William R Lagor
Journal:  Hum Mol Genet       Date:  2016-06-06       Impact factor: 6.150

Review 7.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.

Authors:  Jessica X Chong; Kati J Buckingham; Shalini N Jhangiani; Corinne Boehm; Nara Sobreira; Joshua D Smith; Tanya M Harrell; Margaret J McMillin; Wojciech Wiszniewski; Tomasz Gambin; Zeynep H Coban Akdemir; Kimberly Doheny; Alan F Scott; Dimitri Avramopoulos; Aravinda Chakravarti; Julie Hoover-Fong; Debra Mathews; P Dane Witmer; Hua Ling; Kurt Hetrick; Lee Watkins; Karynne E Patterson; Frederic Reinier; Elizabeth Blue; Donna Muzny; Martin Kircher; Kaya Bilguvar; Francesc López-Giráldez; V Reid Sutton; Holly K Tabor; Suzanne M Leal; Murat Gunel; Shrikant Mane; Richard A Gibbs; Eric Boerwinkle; Ada Hamosh; Jay Shendure; James R Lupski; Richard P Lifton; David Valle; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-07-09       Impact factor: 11.025

8.  TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex.

Authors:  Udaiyappan Janakiraman; Jie Yu; Aubin Moutal; Dhanalakshmi Chinnasamy; Lisa Boinon; Shelby N Batchelor; Annaduri Anandhan; Rajesh Khanna; Mark A Nelson
Journal:  Neurobiol Dis       Date:  2019-07-22       Impact factor: 5.996

9.  Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.

Authors:  Muhammad Ansar; Sohail Aziz Paracha; Alessandro Serretti; Muhammad T Sarwar; Jamshed Khan; Emmanuelle Ranza; Emilie Falconnet; Justyna Iwaszkiewicz; Sayyed Fahim Shah; Azhar Ali Qaisar; Federico A Santoni; Vincent Zoete; Andre Megarbane; Jawad Ahmed; Roberto Colombo; Periklis Makrythanasis; Stylianos E Antonarakis
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

10.  Mutations in WDR4 as a new cause of Galloway-Mowat syndrome.

Authors:  Daniela A Braun; Shirlee Shril; Aditi Sinha; Ronen Schneider; Weizhen Tan; Shazia Ashraf; Tobias Hermle; Tilman Jobst-Schwan; Eugen Widmeier; Amar J Majmundar; Ankana Daga; Jillian K Warejko; Makiko Nakayama; David Schapiro; Jing Chen; Merlin Airik; Jia Rao; Johanna Magdalena Schmidt; Charlotte A Hoogstraten; Hannah Hugo; Jitendra Meena; Monkol Lek; Kristen M Laricchia; Arvind Bagga; Friedhelm Hildebrandt
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.